Hardware Podcasts

Addressing Clinical Trial Challenges & Concerns during COVID-19

Global Medical Device Podcast · 29 Jul 2020 · 38m · Episode 157

What this episode covers

Jon Speer, founder of Greenlight Guru, interviews Isabella Schmitt and Stephanie Mole from Proxima Clinical Research about navigating clinical trials during the COVID-19 pandemic. They discuss the suspension of elective procedures, the shift to remote monitoring and electronic data capture (EDC), and the critical importance of subject safety and protocol amendments. The conversation highlights how companies from non-regulated industries can adapt to medical device regulatory requirements and the long-term industry shift toward digital workflows.

Most relevant to

large enterprises

Topics

Mentioned

Companies
Greenlight Guru, Proxima Clinical Research
Products
Teladoc
Tools
EDC
Also
FDA, NIH

Related episodes from other shows

Other shows on the same ground, closest first.

  • IoT For All Podcast · 29m

    Using IoT to Distribute COVID-19 Vaccines | Luma Health's Aditya Bansod

    Aditya Bansod, Co-Founder and CTO of Luma Health, explains how his company uses IoT and digital platforms to streamline patient engagement and vaccine distribution. He details the evolution of Luma from a smart waitlist tool to a comprehensive platform managing eligibility, scheduling, and remote monitoring for chronic diseases like diabetes. Bansod highlights the critical challenges of healthcare data access, HIPAA compliance, and the need for multi-modal communication to serve diverse patient demographics, including the elderly.

    Connected products & IoTValidation & product-market fit
    7 chapters

  • Moore's Lobby · 1h 19m

    Ep. 15 | The Emergence of the Virtual Supply Chain in a COVID-19 World

    Mark Burr-Lonnon of Mouser Electronics, Dave Doherty of Digi-Key, and Frank McKay of Jabil discuss how the COVID-19 pandemic accelerated the shift to virtual supply chains and e-commerce in the electronics industry. The panelists explain how distributors are adapting by stocking more inventory for new product introductions (NPI) and providing rich technical content to support remote engineers, while Jabil emphasizes the importance of early engagement in design for manufacturing and supply chain transparency. They highlight the resilience of the supply chain despite disruptions in commercial air freight and regional lockdowns, noting that engineers are increasingly relying on digital tools and anonymous purchasing to navigate component shortages.

    Sourcing & supply chainDirect-to-consumer & e-commerce
    7 chapters

  • Being an Engineer · 40m

    Mark Wehde | Engineering at The Mayo Clinic

    Mark Wehde, chair of the Mayo Clinic Division of Engineering, discusses his 30+ year journey from development engineer to executive leader within the Mayo Clinic's unique, in-house engineering group. He details how the team supports clinical innovation by prototyping custom surgical tools and devices, and how the pandemic forced a rapid pivot to reverse-engineering PPE and scaling production of face shields and respirators. Wehde also explores the future of remote healthcare, the regulatory challenges of integrating consumer wearables into medical practice, and the cultural emphasis on patient-centricity and staff wellbeing at the organization.

    Medical & health devicesLeadership, teams & culture
    7 chapters

  • Let's Combinate · 1h 13m

    038 - "Clinical Trials" with Dan Sfera

    Dan Sfera, founder of Yuma Clinical Trials and author of the Comprehensive Guide to Clinical Research, explains the operational realities of clinical trials, highlighting the conflict between 'patient-centric' technology and actual patient burden. He details the high screen-failure rates in Phase 2 and 3 trials, the critical role of the Investigator's Form 1572, and the specific risks of investigational product mix-ups during randomization. Sfera also discusses the dynamics between sponsors, CROs, and sites, arguing that direct sponsor involvement often yields better outcomes than using rigid CROs.

    Validation & product-market fitQuality & yield
    10 chapters

  • Let's Combinate · 8m

    Combi Crumbs: Clinical Trials 101 – From Safety to Strategy

    Archana Sah, a clinical development expert with over 30 years of experience, explains the critical phases of clinical trials for drug approval. She details how Phase 1 focuses on safety and PK/PD measurements, while Phase 2 and 3 assess efficacy in diverse populations, often comparing new drugs against standard-of-care treatments in oncology. Sah emphasizes the importance of protocol design, regulatory alignment with the FDA, and incorporating patient-reported outcomes to capture the patient experience. She also discusses the logistical complexities of patient recruitment, site selection, and the role of various vendors in executing decentralized or hybrid trial models.

    Validation & product-market fitPolicy, trade & tariffs
    2 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.